Status: Not yet recruiting
A Clinical Trail of Adalimumab in Treating Chinese Children With Severe Plaque Psoriasis
This study is a real-world clinical study of adalimumab. The project plans to enrol 30 participants and aims to evaluate the efficacy and safety of adalimumab in Chinese children with plaque psoriasis, with the primary endpoint being the proportion of participants achieving PASI 75 (PASI score reduction ≥75% from baseline) at week 16.
Participants needed: 30
Trial details
Phase: Phase 4Age: 4-17Biological sex: AllType: InterventionalSponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Updated: Apr 14, 2026
Eligibility criteria
Subjects and their guardians must sign an informed consent form. The research pr... [+4]
Based on the prescribing information of Adalimumab Solution for Injection and th... [+7]